PCSK9 inhibitors: A new era of lipid lowering therapy

Chaudhary, Rahul; Garg, Jalaj; Shah, Neeraj; D. Sumner, Andrew

doi:10.4330/wjc.v9.i2.76

Public

PCSK9 inhibitors: A new era of lipid lowering therapy

Published in World Journal of Cardiology • Jan 1, 2017

Authors:

Rahul Chaudhary

Jalaj Garg

Neeraj Shah

Abstract

Hyperlipidemia is a well-established risk factor for developing cardiovascular disease (CVD). The recent American College of Cardiology and American Heart Association guidelines on lipid management emphasize treatment of individuals at increased risk for developing CVD events with 3-hydroxy-3-methyl...

Subject

Evolocumab

Alirocumab

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!